Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Jul 11, 2019 3:08pm
66 Views
Post# 29909973

RE:RE:RE:RE:Someone wants out - Good Story

RE:RE:RE:RE:Someone wants out - Good Story
robertshaw wrote:
Watchmen wrote: Not so sure giving away undervalued sahres/plus warrant is a good sign. Not only do the people doing the giving (and receiving in this case) have a great deal more info in front of them, they have done very little-nothing to properly value the company on behalf of all shareholders, which is the only reason for a public company to exist by the way.

I will agree with you that people want to buy things as cheaply as possible and turn a profit. But if you are hurting and in effect punishing your current shareholders to do so it could be taken as contrary to your duties as a public company manager

The proper way to go about this is to drive the maximum value (share price) possible and attempt a financing at fair valuation levels. They have accomplished the opposite here by driving no value over the past 12 months and even at these very low levels attaching a warrant. Theralase claims to be a clinical stage company but they play in the junior bush leagues on their capital raises.

this is the type of financing a near death cororations throws out as a lst gasp

What did the ex but still employed CEO value a P2 company at? was it 5 times this level or 10- times


I think the former and current management all look like a pimp, RW once boost the company's value before the clinical stage should be over $100Million, and for the phase1 human trial successfully finished, should be valued as $300 million over, yet the pimps kept hooking shameless blowjobboss to do endless cheap PPs to screw its royal shareholders with mercy... why should we still allow the pimps to stay at the management position????


The pimps kept doing shameless PP WITHOUT mercy, Missed spelling.
Bullboard Posts